BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1816075)

  • 1. Hybridomas can successfully be prepared from frozen/thawn spleen cells.
    Bennick A; Grøn B; Brosstad F
    Hybridoma; 1991 Dec; 10(6):761-5. PubMed ID: 1816075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single shot intrasplenic immunization: an advantageous procedure for production of monoclonal antibodies specific for human fibrin fragments.
    Thorpe R; Perry MJ; Callus M; Gaffney PJ; Spitz M
    Hybridoma; 1984; 3(4):381-5. PubMed ID: 6526403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies from rats immunized with fragment D of human fibrinogen.
    Kennel SJ; Chen JP; Lankford PK; Foote LJ
    Thromb Res; 1981 May; 22(3):309-20. PubMed ID: 7302901
    [No Abstract]   [Full Text] [Related]  

  • 4. Making monoclonal antibodies.
    Asai DJ; Wilder JK
    Methods Cell Biol; 1993; 37():57-74. PubMed ID: 8255250
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryopreservation of newly formed human and mouse hybridoma cells.
    Settmacher U; Jahn S; Grunow R; Mehl M; von Baehr R
    Allerg Immunol (Leipz); 1989; 35(3):195-201. PubMed ID: 2816666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on monoclonal antibodies to human von Willebrand factor].
    Ruan CG; Xi XD; Gu JM
    Zhonghua Nei Ke Za Zhi; 1986 Sep; 25(9):547-50, 576. PubMed ID: 3492345
    [No Abstract]   [Full Text] [Related]  

  • 7. Fusion of myeloma cells with immune spleen cells.
    Fuller SA; Takahashi M; Hurrell JG
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.7. PubMed ID: 18265079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells.
    Enriquez FJ; Bradley-Dunlop D; Joens L
    Hybridoma; 1991 Dec; 10(6):745-51. PubMed ID: 1816073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient hybridoma production using previously frozen splenocytes.
    Marusich MF
    J Immunol Methods; 1988 Nov; 114(1-2):155-9. PubMed ID: 3183388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for selecting specific hybridoma clones using paramagnetic Dynabeads.
    Bennick A; Brosstad F
    Scand J Immunol; 1993 Sep; 38(3):212-4. PubMed ID: 8356396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A freezing method for cell fusions to distribute and reduce labor and permit more thorough early evaluation of hybridomas.
    Harwell LW; Bolognino M; Bidlack JM; Knapp RJ; Lord EM
    J Immunol Methods; 1984 Jan; 66(1):59-67. PubMed ID: 6363553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
    Neil GA; Sammons DW
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain.
    Matsumoto T; Nishijima Y; Teramura Y; Fujino K; Hibino M; Hirata M
    Thromb Res; 1985 May; 38(3):297-302. PubMed ID: 2410999
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of postfusion cell density on establishment of hybridomas.
    Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
    Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreservation of spleen and lymph nodes as a source of mononuclear cells to be used for the development of monoclonal antibody producing hybridoma cells.
    Sogut I; Hatipoglu I; Serhatli M; Cevik SI; Durali D; Basalp A
    Cryo Letters; 2011; 32(3):266-74. PubMed ID: 21766156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freezing and recovery of hybridoma cell lines.
    Fuller SA; Takahashi M; Hurrell JG
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.9. PubMed ID: 18265081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
    Gargan PE; Ploplis VA; Scheu JD
    Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and application of hybridoma secreting monoclonal antibody against poly-human serum albumin].
    Cai MY; Zhang ZK; Mu JW; Wang CX; Yin TY; Li MY; Liu L; Zhao ZR; Wang DR
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):134-6. PubMed ID: 2591920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryopreservation of newly formed hybridomas.
    De Leij L; Poppema S; The TH
    J Immunol Methods; 1983 Aug; 62(1):69-72. PubMed ID: 6875266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.